Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

South Korea · Delayed Price · Currency is KRW

5,640.00

-10.00 (-0.18%)

At close: Apr 21, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Others			7.84B	13.84B	12.46B	9.21B	8.71B
Others Growth			-43.35%	11.05%	35.29%	5.76%	-38.12%
Pharmaceutical Sector			153.26B	167.07B	163.89B	163.70B	167.76B
Pharmaceutical Sector Growth			-8.27%	1.94%	0.11%	-2.42%	0.62%
Rental Sector			3.62B	3.02B	2.93B	2.83B	2.50B
Rental Sector Growth			19.79%	3.17%	3.50%	13.03%	-8.50%
Adjustments and Removal			-2.05B	-1.22B	-1.67B	-1.92B	-2.48B
Total			162.67B	182.72B	177.61B	173.83B	176.50B
Total Growth			-10.97%	2.88%	2.18%	-1.51%	-1.57%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			162.59B	182.57B	177.46B	173.61B	176.11B
South Korea Growth			-10.94%	2.88%	2.22%	-1.42%	-1.50%
United States of America			80.26M	151.28M	154.83M	222.08M	391.23M
United States of America Growth			-46.95%	-2.29%	-30.28%	-43.24%	-26.53%
Total			162.67B	182.72B	177.61B	173.83B	176.50B
Total Growth			-10.97%	2.88%	2.18%	-1.51%	-1.57%

Source: S&P Global Market Intelligence.